Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Imaging and lipidomics methods for lipid analysis in metabolic and cardiovascular disease|
|Citation:||Proceedings of the Scientific Meeting on Australia and New Zealand Developmental Origins of Health and Disease (2016 ANZ DOHaD), as published in Journal of Developmental Origins of Health and Disease, 2017 / vol.8, iss.5, pp.566-574|
|Publisher:||Cambridge University Press|
|Conference Name:||Scientific Meeting on Australia and New Zealand Developmental Origins of Health and Disease (2016 ANZ DOHaD) (2016 : Melbourne, AUSTRALIA)|
|K. G. Stevens, C. A. Bader, A. Sorvina, D. A. Brooks, S. E. Plush and J. L. Morrison|
|Abstract:||Cardiometabolic diseases exhibit changes in lipid biology, which is important as lipids have critical roles in membrane architecture, signalling, hormone synthesis, homoeostasis and metabolism. However, Developmental Origins of Health and Disease studies of cardiometabolic disease rarely include analysis of lipids. This short review highlights some examples of lipid pathology and then explores the technology available for analysing lipids, focussing on the need to develop imaging modalities for intracellular lipids. Analytical methods for studying interactions between the complex endocrine and intracellular signalling pathways that regulate lipid metabolism have been critical in expanding our understanding of how cardiometabolic diseases develop in association with obesity and dietary factors. Biochemical methods can be used to generate detailed lipid profiles to establish links between lifestyle factors and metabolic signalling pathways and determine how changes in specific lipid subtypes in plasma and homogenized tissue are associated with disease progression. New imaging modalities enable the specific visualization of intracellular lipid traffic and distribution in situ. These techniques provide a dynamic picture of the interactions between lipid storage, mobilization and signalling, which operate during normal cell function and are altered in many important diseases. The development of methods for imaging intracellular lipids can provide a dynamic real-time picture of how lipids are involved in complex signalling and other cell biology pathways; and how they ultimately regulate metabolic function/homoeostasis during early development. Some imaging modalities have the potential to be adapted for in vivo applications, and may enable the direct visualization of progression of pathogenesis of cardiometabolic disease after poor growth in early life.|
|Keywords:||cardiometabolic diseases; imaging; lipidomics|
|Description:||Australian Perspectives: Outcomes from the 2016 ANZ DOHaD Scientific Meeting|
|Rights:||© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2017|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.